337 related articles for article (PubMed ID: 17278974)
1. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension.
Zieman SJ; Melenovsky V; Clattenburg L; Corretti MC; Capriotti A; Gerstenblith G; Kass DA
J Hypertens; 2007 Mar; 25(3):577-83. PubMed ID: 17278974
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
[TBL] [Abstract][Full Text] [Related]
3. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.
Hartog JW; Willemsen S; van Veldhuisen DJ; Posma JL; van Wijk LM; Hummel YM; Hillege HL; Voors AA;
Eur J Heart Fail; 2011 Aug; 13(8):899-908. PubMed ID: 21669961
[TBL] [Abstract][Full Text] [Related]
4. Effects of sodium nitrite supplementation on vascular function and related small metabolite signatures in middle-aged and older adults.
DeVan AE; Johnson LC; Brooks FA; Evans TD; Justice JN; Cruickshank-Quinn C; Reisdorph N; Bryan NS; McQueen MB; Santos-Parker JR; Chonchol MB; Bassett CJ; Sindler AL; Giordano T; Seals DR
J Appl Physiol (1985); 2016 Feb; 120(4):416-25. PubMed ID: 26607249
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end-products and arterial stiffness in hypertension.
McNulty M; Mahmud A; Feely J
Am J Hypertens; 2007 Mar; 20(3):242-7. PubMed ID: 17324733
[TBL] [Abstract][Full Text] [Related]
6. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients.
Plantinga Y; Ghiadoni L; Magagna A; Giannarelli C; Franzoni F; Taddei S; Salvetti A
Am J Hypertens; 2007 Apr; 20(4):392-7. PubMed ID: 17386345
[TBL] [Abstract][Full Text] [Related]
7. The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial.
Oudegeest-Sander MH; Olde Rikkert MG; Smits P; Thijssen DH; van Dijk AP; Levine BD; Hopman MT
Exp Gerontol; 2013 Dec; 48(12):1509-17. PubMed ID: 24400341
[TBL] [Abstract][Full Text] [Related]
8. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.
Kass DA; Shapiro EP; Kawaguchi M; Capriotti AR; Scuteri A; deGroof RC; Lakatta EG
Circulation; 2001 Sep; 104(13):1464-70. PubMed ID: 11571237
[TBL] [Abstract][Full Text] [Related]
9. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.
Vaitkevicius PV; Lane M; Spurgeon H; Ingram DK; Roth GS; Egan JJ; Vasan S; Wagle DR; Ulrich P; Brines M; Wuerth JP; Cerami A; Lakatta EG
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1171-5. PubMed ID: 11158613
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Garg N; Kaur L; Chand P
Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
[TBL] [Abstract][Full Text] [Related]
11. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Horio T; Yoshimasa Y; Harano Y
Am J Hypertens; 2004 Mar; 17(3):228-32. PubMed ID: 15001196
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus.
Sidhu JS; Cowan D; Kaski JC
Am J Cardiol; 2004 Jul; 94(2):151-6. PubMed ID: 15246889
[TBL] [Abstract][Full Text] [Related]
13. Aging and vascular responses to flavanol-rich cocoa.
Fisher ND; Hollenberg NK
J Hypertens; 2006 Aug; 24(8):1575-80. PubMed ID: 16877960
[TBL] [Abstract][Full Text] [Related]
14. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women.
Teede HJ; McGrath BP; DeSilva L; Cehun M; Fassoulakis A; Nestel PJ
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1066-71. PubMed ID: 12714433
[TBL] [Abstract][Full Text] [Related]
15. Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production.
Andersen GN; Mincheva-Nilsson L; Kazzam E; Nyberg G; Klintland N; Petersson AS; Rantapää-Dahlqvist S; Waldenström A; Caidahl K
Arthritis Rheum; 2002 May; 46(5):1324-32. PubMed ID: 12115240
[TBL] [Abstract][Full Text] [Related]
16. Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study.
van Bussel BC; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Stehouwer CD
J Hypertens; 2012 Apr; 30(4):744-52. PubMed ID: 22343535
[TBL] [Abstract][Full Text] [Related]
17. Effect of deferasirox (ICL670) on arterial function in patients with beta-thalassaemia major.
Cheung YF; Chan GC; Ha SY
Br J Haematol; 2008 May; 141(5):728-33. PubMed ID: 18318756
[TBL] [Abstract][Full Text] [Related]
18. Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease.
Beigel R; Dvir D; Arbel Y; Shechter A; Feinberg MS; Shechter M
Vasc Med; 2010 Aug; 15(4):299-305. PubMed ID: 20724375
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function.
Stewart KJ; Sung J; Silber HA; Fleg JL; Kelemen MD; Turner KL; Bacher AC; Dobrosielski DA; DeRegis JR; Shapiro EP; Ouyang P
Am J Hypertens; 2004 Apr; 17(4):314-20. PubMed ID: 15062884
[TBL] [Abstract][Full Text] [Related]
20. Systolic and diastolic hypertension impair endothelial vasodilatory function in different types of vessels in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
Lind L
J Hypertens; 2006 Jul; 24(7):1319-27. PubMed ID: 16794481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
